ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1629

Functional Effect Of NR1H3 (LXRA) Promoter Polymorphisms In Korean Patients With Systemic Lupus Erythematosus

Ja-Young Jeon1, Hyoun-Ah Kim1, Ju-Yang Jung1 and Chang-Hee Suh2, 1Department of Rheumatology, Ajou University School of Medicine, Suwon, South Korea, 2Department of Rheumatology, Ajou University Hospital, Suwon, South Korea

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: B cells, genetics, pathogenesis, polymorphism and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus-Human Etiology and Pathogenesis: Genetics and Genomics

Session Type: Abstract Submissions (ACR)

Background/Purpose: Liver X receptor alpha (LXRA, NR1H3) and beta (LXRB, NR1H2) can influence macrophage biology by modulation of lipid metabolism and by effects on innate immunity. The recent studies have reported that LXRs are involved in regulation of inflammation and immune responses.  In our previous data, we have identified five polymorphisms (-1851 T>C, -1830 T>C, -1003 G>A, -840 C>A and -115 G>A) including one novel SNPs (-1003 G>A) in the NR1H3 gene. Especially, the -1830 T>C promoter polymorphism was significantly different in genotype analysis and clinical manifestations. This study evaluated the functional effect of the NR1H3 promoter polymorphism on systemic lupus erythematosus.

Methods: The promoter activity was analyzed by luciferase reporter assay in Hep3B cells and COS-7 cells. To investigate the effects of the stimulation, we used a functional assay of transcriptional activity and B cell proliferation assay with lipopolysaccharide, GW3965 and T0901317. The mRNA expression of NR1H3 gene according to the genotype was analyzed by RT-PCR and quantitative real-time PCR. To investigate whether the genetic polymorphism changed a transcription factor binding, we performed an electrophoretic mobility shift assay (EMSA).

Results: Luciferase activity of the constructs containing -1830 C was lower than that of the constructs containing -1830 T (p=0.009). Moreover, promoter activity of the -1830 C was less enhanced compared to that of the -1830 T in GW3965 and T0901317 treated cells (p=0.034 and p<0.001, respectively). Proliferation of -1830 TC type was increased compared to that of -1830 TT type in basal, GW3965 and T0901317 treated B cells from SLE patients (p=0.011, p= 0.040 and p=0.017, respectively). The -1830 TC type B cells displayed lower NR1H3 mRNA expression level than the -1830 TT type B cells in both SLE and NC. Moreover, NR1H3 expression level significantly different between genotypes in real-time PCR. In both SLE and NC, the -1830 TC type was an approximately 1.8-fold decrease than the -1830 TT type. EMSA using nuclear extracts prepared from Hep3B cells revealed a specific band with the -1830 T probe, but not with the -1830 C probe. We performed a competition assay using GATA-3 probes, and found that the shifted band corresponding to the -1830 T probe was completely competed for by the unlabeled GATA-3 probe. The -1830 T specific band was also competed by anti-GATA-3 antibodies but not supershifted.

Conclusion: These results suggest that the NR1H3 gene -1830 T>C promoter polymorphism may be involved in regulation of NR1H3 expression.


Disclosure:

J. Y. Jeon,
None;

H. A. Kim,
None;

J. Y. Jung,
None;

C. H. Suh,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/functional-effect-of-nr1h3-lxra-promoter-polymorphisms-in-korean-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology